<DOC>
	<DOCNO>NCT02936128</DOCNO>
	<brief_summary>The purpose study compare clinical outcome TruSkin® Active Comparator patient chronic venous leg ulcer .</brief_summary>
	<brief_title>TruSkin® : Study Treatment Chronic Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Between 18 year 80 year age inclusive , date screen 2 . An Index Ulcer chronic ( defined present &gt; 4 week , present 52 week Screening Visit ) 3 . Index Ulcer locate leg , knee 4 . The Index Ulcer Venous Leg Ulcer ( VLU ) great 10 cm2 , inclusive , Screening Visit 5 . The long length long width measurement Index Ulcer le 1 cm Screening Visit 6 . The Index Ulcer extend dermis subcutaneous tissue without evidence expose muscle , tendon , bone , joint capsule 7 . Wound free necrotic debris 8 . Patient adequate circulation foot document Ankle Brachial Index ( ABI ) Toe Brachial Index ( TBI ) 9 . Confirmed diagnosis venous insufficiency duplex ultrasonography demonstrate reflux ≥ 0.5 second superficial low extremity venous system . 1 . Index Ulcer nonvenous pathophysiology 2 . Gangrene present part affect limb 3 . Patient currently receive dialysis planning go dialysis 4 . Patient glycated hemoglobin A1c ( HbA1c ) level &gt; 12 % 5 . Chronic oral steroid use &gt; 7.5 mg daily longer 3 month time screen 6 . Patient receive IV corticosteroid , immunosuppressive cytotoxic agent time screen 7 . Requiring intravenous ( IV ) antibiotic treat index wound infection time screen 8 . Patient ulcer within 5 cm Index Ulcer identify study consideration 9 . Patient Human Immunodeficiency Virus ( HIV ) positive Acquired Immune Deficiency Syndrome ( AIDS ) 10 . Current evidence cellulitis , evidence infection include fever pu drainage wind site 11 . Current evidence osteomyelitis history osteomyelitis within 30 day screen 12 . Patient active malignancy nonmelanoma skin cancer 13 . Patient 's Index Ulcer decrease ≥ 20 % 1week screening period 14 . Patient 's random blood sugar &gt; 450 mg/dl screen 15 . Patient unable receive compression therapy part standard care 16 . Patient untreated alcohol substance abuse time screen 17 . Pregnant woman woman breastfeed 18 . Patient currently enrol participate another investigational device , drug , biological trial within 30 day screen 19 . Patient within last 30 day , currently undergo , plan wound treatment growth factor , live skin , dermal substitute advance biological therapy 20 . Patient employee , immediate family member employee , sponsor company site research staff conduct study 21 . Patients already randomize Protocol 352 center may consider screen reentry trial center , even End Study Visit 22 . Patients history poor compliance , unwillingness inability adhere requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>